Targeting Cancer Metabolism
Researchers from Tyme Technologies are focusing on cancer cell metabolism, particularly tyrosine, as a way to kill cancer cells.
Yolanda is a 10-year survivor of Pancreatic Cancer
Yolanda L. Jackson is a long-term survivor of pancreatic cancer. She worked throughout her treatment, despite side effects, and is now living her life with a “new normal.”
Announcing the Pancreatic Cancer Collective
The Lustgarten Foundation and Stand Up To Cancer have joined forces for a research partnership called the Pancreatic Cancer Collective.
Testing a New Drug on Advanced Pancreatic Neuroendocrine Tumors
In a clinical trial, the new drug sapanisertib is being tested for its effectiveness against pancreatic neuroendocrine tumors (PNETs).
Genetic Testing Can Help Those You Love
Dr. Fay Kastrinos, director of the Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program at Columbia University Medical Center, explains the value of genetic testing for cancer prevention and treatment.
Scanxiety—A Nearly Universal Experience Among Cancer Patients
Social worker Lauren Shaffer provides tips and insights into managing scanxiety, the worry that accompanies follow-up scans and tests for cancer patients.
Lustgarten Foundation Appoints David Tuveson, M.D., Ph.D., Chief Scientist
Dr. David Tuveson has been appointed the chief scientist for the Lustgarten Foundation. He specializes in pancreatic cancer reseach at the Cold Spring Harbor Labs.
A Routine Physical Saved My Life
John Moisan’s doctor noticed he had lost weight, and insisted he get an abdominal CT scan. His doctor’s insistence saved John’s life, because they found a pancreatic tumor.
Radiation and Chemotherapy to Make Pancreatic Cancer Surgically Removable
Can a combination of radiation and chemotherapy make pancreatic tumors that are borderline removeable better candidates for surgery? A clinical trial looks at this question.
Reimagining the Possible: A 20-year Survivor of Pancreatic Cancer
Marisa is a 20-year survivor of stage IV pancreatic cancer as of Spring 2018. She focused on those who defied the odds, and now she is thriving.